- Home
- FBIO vs OPRX Comparison
FBIO vs OPRX Comparison
Compare FBIO & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBIO | OPRX |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | 78 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.6M | 96.1M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | FBIO | OPRX |
|---|---|---|
| Price | $3.37 | $6.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $17.00 | $16.67 |
| AVG Volume (30 Days) | ★ 611.0K | 485.2K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $109,429,000.00 |
| Revenue This Year | $55.22 | $3.88 |
| Revenue Next Year | $40.55 | $8.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $1.77 | $4.54 |
| 52 Week High | $4.53 | $22.25 |
Technical Indicators
Market Signals| Indicator | FBIO | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 58.98 | 68.77 |
| Support Level | $3.28 | $5.80 |
| Resistance Level | $3.80 | $7.10 |
| Average True Range (ATR) | 0.22 | 0.33 |
| MACD | 0.03 | 0.09 |
| Stochastic Oscillator | 59.46 | 85.33 |
Price Performance
Historical ComparisonAbout FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.